Agios Pharmaceuticals Inc Investor Event (Virtual) Transcript
All right. Good morning, everyone. Welcome to Agios EHA webcast. I will go ahead and share our slides and then kick it off to Jackie to get us started.
Thank you, Holly. Good morning, everybody. Hope everybody is doing well, and thanks for joining us at this EHA 2022 event. One of the things that we like to emphasize, well, we don't so much want to emphasize the forward-looking statements, so we need to do that. So here they are. And then subsequent to that, one of the things that I want to point out real quick is just the agenda, and then I've got a couple of introductory slides. So my remarks will be very brief, so we can get to the more interesting, more important parts of the event today.
You'll hear from Sarah regarding an update on pyruvate kinase deficiency and the story that is playing out very nicely for us there. She will also talk about thalassemia and the burden of disease and where we are with the
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
